BDBM72331 MLS000393196::N-(2-chloranyl-5-morpholin-4-ylsulfonyl-phenyl)-2-[3-(4-methylphenyl)-4-oxidanylidene-quinazolin-2-yl]sulfanyl-ethanamide::N-(2-chloro-5-morpholin-4-ylsulfonylphenyl)-2-[3-(4-methylphenyl)-4-oxoquinazolin-2-yl]sulfanylacetamide::N-(2-chloro-5-morpholinosulfonyl-phenyl)-2-[[4-keto-3-(p-tolyl)quinazolin-2-yl]thio]acetamide::N-[2-chloro-5-(4-morpholinylsulfonyl)phenyl]-2-[[3-(4-methylphenyl)-4-oxo-2-quinazolinyl]thio]acetamide::SMR000248026::cid_3260312
SMILES Cc1ccc(cc1)-n1c(SCC(=O)Nc2cc(ccc2Cl)S(=O)(=O)N2CCOCC2)nc2ccccc2c1=O
InChI Key InChIKey=LXVNDMOMBGXXGK-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 72331
TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development
US Patent
Glaxosmithkline Intellectual Property Development
US Patent
Affinity DataIC50: 6.31nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
